Carfilzomib Works Well As Salvage Treatment; Momentum Builds For Frontline Role

Small study of Onyx' proteasome inhibitor shows potential for replacing Velcade in combination with Revlimid and dexamethasone in newly diagnosed multiple myeloma patients.